TENX
Tenax Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.87
+5.06%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.38
- Revenue estimate
- —
Latest reported
- Last report date
- Jul 31, 2026
- EPS actual
- -$0.35
- EPS estimate
- -$0.38
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +34.2%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $17
- PT range
- $4.00 – $50
- Analysts
- 7
3 Buy4 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026